Fortress Biotech, Inc. (FBIO) is a publicly traded Healthcare sector company. As of May 21, 2026, FBIO trades at $2.65 with a market cap of $82.38M and a P/E ratio of 0.69. FBIO moved +4.74% today. Year to date, FBIO is -37.94%; over the trailing twelve months it is +51.43%. Its 52-week range spans $1.33 to $4.53. Analyst consensus is buy with an average price target of $10.75. Rallies surfaces FBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes FBIO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $2.65 |
| Market Cap | $82.38M |
| P/E Ratio | 0.69 |
| EPS | $3.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.53 |
| 52-Week Low | $1.33 |
| Volume | 584 |
| Avg Volume | 0 |
| Revenue (TTM) | $66.16M |
| Net Income | $128.94M |
| Gross Margin | 66.22% |
2 analysts cover FBIO: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.75.